Bluebird Bio Prices Public Offering Of 20 Mln Shares At $6.00/shr

bluebird bio Inc. (BLUE) said that it has priced its underwritten public offering of 20 million shares of its common stock at a public offering price of $6.00 per share, before deducting underwriting discounts and commissions.

bluebird also granted the underwriters a 30-day option to purchase up to an additional 3 million shares of its common stock at the public offering price per share, less underwriting discounts and commissions.

The company expects the gross proceeds from the public offering to be $120 million, before deducting underwriting discounts and commissions and offering expenses payable by bluebird.

The company plans to use the net proceeds of the offering to support commercialization and manufacturing for its two approved gene therapies, Zynteglo And Skysona; to accelerate future commercialization activities for its gene therapy candidate, lovotibeglogene autotemcel for sickle cell disease, if approved; and to fund working capital and other general corporate purposes.

The offering is expected to close on or about January 23, 2023.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The US Food and Drug Administration has cleared cultivated chicken developed by GOOD Meat Inc., the cultivated meat division of alternative foods startup Eat Just Inc. This is FDA's second pre-market consultation for a human food made from cultured animal cells after UPSIDE Foods. GOOD Meat is now required to meet Federal requirements including approvals from the US Department of Agriculture. A group of 23 U.S. states attorneys general have asked South Korean car manufacturers Hyundai Motor and Kia Corp. to take action more quickly to solve problems with millions of U.S. vehicles facing theft. The issue is related to the companies' failure to equip vehicles with anti-theft immobilizers, which has been a standard equipment on vehicles sold by other major manufacture El Monte, California-based Mutual Trading Co., Inc. is recalling certain Kagome Sauces citing undeclared soy, a known allergen, the U.S. Food and Drug Administration said. The recall involves 60 fl oz of Kagome Worcester Sauce, 10 fl oz of Kagome Chuno sauce, and 8g of Kagome Take out Tonkatsu Sauce.
Follow RTT